Chemoinformaics analysis of PENTANE-1,3,4-TRICARBOXYLIC-ACID
| Molecular Weight | 204.266 | nRot | 6 |
| Heavy Atom Molecular Weight | 184.106 | nRig | 1 |
| Exact Molecular Weight | 204.136 | nRing | 0 |
| Solubility: LogS | -0.623 | nHRing | 0 |
| Solubility: LogP | 1.354 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 33.2439 |
| nHD | 2 | BPOL | 21.8001 |
| QED | 0.582 |
| Synth | 1.486 |
| Natural Product Likeliness | 0.563 |
| NR-PPAR-gamma | 0.444 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.004 |
| HIA | 0.01 |
| CACO-2 | -4.754 |
| MDCK | 0.0000888 |
| BBB | 0.88 |
| PPB | 0.574294 |
| VDSS | 0.244 |
| FU | 0.50916 |
| CYP1A2-inh | 0.036 |
| CYP1A2-sub | 0.315 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.238 |
| CYP2c9-inh | 0.008 |
| CYP2c9-sub | 0.936 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.224 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.046 |
| CL | 6.537 |
| T12 | 0.803 |
| hERG | 0.011 |
| Ames | 0.009 |
| ROA | 0.117 |
| SkinSen | 0.186 |
| Carcinogencity | 0.178 |
| EI | 0.991 |
| Respiratory | 0.073 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.844756 |